SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mad2 who wrote (828)8/30/1999 12:44:00 AM
From: DanZ   of 5582
 
Mad2,

It seems like you rehash the same issues over and over again, especially when you can't get anywhere with your "new" issues. We previously discussed GumTech's contribution of $3.5 million to initially fund the joint venture with Gel Tech and I have no desire to rehash it again. I disagree that it is a bad deal for GumTech shareholders although I do agree that GumTech took some risk. We can debate until the cows come home whether GumTech took too much risk in return for 60% ownership in a cold remedy that is clinically proven to reduce the duration of the common cold to 1.5 days, and targets a $1.5 billion domestic market. Here's my prediction: That $3.5 million will go down in history as the investment that catapulted GumTech to its success and is minuscule compared to the potential return to shareholders.

<how is the Citiadl Prefered issue not dilutive?>

Gee, this conversation started with your opinion that the Citadel financing is dilutive and "yuk". I asked you to describe why you think it's dilutive and yuk, and now you respond by asking me why it isn't dilutive. I'm not going to play this game with you. You started this conversation and it's up to you to substantiate your claim.

The risk factors that you described are normal disclosures that appear in any company's SEC filings. They are of little concern to me or anyone else and state the obvious. They protect the company and its shareholders from frivolous lawsuits and serve no other useful purpose. Does anything other than the standard risk disclosures in the S-3 or 8-K bother you?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News